Evidence map›Paper›PMID 32127037›Full record

ArticleStem cell research & therapy2020

Mesenchymal stem cell-derived exosomes protect beta cells against hypoxia-induced apoptosis via miR-21 by alleviating ER stress and inhibiting p38 MAPK phosphorylation.

Jin Chen, Junqiu Chen, Yuanhang Cheng, Yunfeng Fu, Hongzhou Zhao, Minying Tang, Hu Zhao, Na Lin, Xiaohua Shi, Yan Lei and 4 more

Open access · goldAbstract read
In one paragraph

Article in Stem cell research & therapy, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 139 papers.

0numbers the graph read from it
0cells of the map it votes in
139citing papers in PubMed
10.0field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

139 citing papers in PubMed, 204 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Review
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Article
  18. Review
  19. Article
  20. Review

79 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors at 1 institution in 1 country.

Jin ChenFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China. kingchen81@qq.com.ORCID 0000-0003-0794-3995
Junqiu ChenFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Yuanhang ChengFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Yunfeng FuFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Hongzhou ZhaoFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Minying TangFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Hu ZhaoFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Na LinFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Xiaohua ShiFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Yan LeiFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Shuiliang WangFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China. shuiliang.wang@xmu.edu.cn.
Lianghu HuangFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Weizhen WuFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China. 13905915547@163.com.
Jianming TanFujian Provincial Key Laboratory of Transplant Biology, 900th Hospital, Xiamen University, 156th XiErHuan Road, Fuzhou, 350025, China.
Fujian Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundHypoxia is a major cause of beta cell death and dysfunction after transplantation. The aim of this study was to investigate the effect of exosomes derived from mesenchymal stem cells (MSCs) on beta cells under hypoxic conditions and the potential underlying mechanisms.

methodsExosomes were isolated from the conditioned medium of human umbilical cord MSCs and identified by WB, NTA, and transmission electron microscopy. Beta cells (βTC-6) were cultured in serum-free medium in the presence or absence of exosomes under 2% oxygen conditions. Cell viability and apoptosis were analysed with a CCK-8 assay and a flow cytometry-based annexin V-FITC/PI apoptosis detection kit, respectively. Endoplasmic reticulum stress (ER stress) proteins and apoptosis-related proteins were detected by the WB method. MiRNAs contained in MSC exosomes were determined by Illumina HiSeq, and treatment with specific miRNA mimics or inhibitors of the most abundant miRNAs was used to reveal the underlying mechanism of exosomes.

resultsExosomes derived from MSC-conditioned culture medium were 40-100 nm in diameter and expressed the exosome markers CD9, CD63, CD81, HSP70, and Flotillin 1, as well as the MSC markers CD73, CD90, and CD105. Hypoxia significantly induced beta cell apoptosis, while MSC exosomes remarkably improved beta cell survival. The WB results showed that ER stress-related proteins, including GRP78, GRP94, p-eIF2α and CHOP, and the apoptosis-related proteins cleaved caspase 3 and PARP, were upregulated under hypoxic conditions but were inhibited by MSC exosomes. Moreover, the p38 MAPK signalling pathway was activated by hypoxia and was inhibited by MSC exosomes. The Illumina HiSeq results show that MSC exosomes were rich in miR-21, let-7 g, miR-1246, miR-381, and miR-100. After transfection with miRNA mimics, the viability of beta cells under hypoxia was increased significantly by miR-21 mimic, and the p38 MAPK and ER stress-related proteins in beta cells were downregulated. These changes were reversed after exosomes were pretreated with miR-21 inhibitor.

conclusionsExosomes derived from MSCs could protect beta cells against apoptosis induced by hypoxia, largely by carrying miR-21, alleviating ER stress and inhibiting p38 MAPK signalling. This result indicated that MSC exosomes might improve encapsulated islet survival and benefit diabetes patients.

Indexed as

ExosomesMesenchymal Stem CellsMicroRNAsApoptosisEndoplasmic Reticulum Chaperone BiPEndoplasmic Reticulum StressHumansHypoxiap38 Mitogen-Activated Protein KinasesPhosphorylationEndoplasmic Reticulum Chaperone BiPHSPA5 protein, humanMicroRNAsMIRN21 microRNA, humanp38 Mitogen-Activated Protein KinasesBeta cellsER stressExosomesHypoxiaMesenchymal stem cells

Identifiers

PMID32127037
PMCPMC7055095
OpenAlexW3009111872

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.